India Stock Market Daily Regulatory Digest — August 23, 2026

23-08-2026

Jubilant Pharmova announced that the USFDA has approved commercial batch manufacturing for the first product on Line 3, a new isolator-based fill and finish line, at its Jubilant HollisterStier LLC contract manufacturing facility in Spokane, USA. This approval expands the company's sterile injectable manufacturing capacity. No financial figures or period-over-period comparisons were provided in the filing.

• · USFDA approval received on August 21, 2026 (PST) / August 22, 2026 (IST).
• · Line 3 is an isolator-based fill and finish line for sterile injectables.
• · Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., which is a subsidiary of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of Jubilant Pharmova Limited.
• · Jubilant Pharmova has a team of around 5,500 people globally.
• · The company operates 45 radio-pharmacies in the USA.

23-08-2026

Quantum Digital Vision (India) Ltd. held its 46th AGM on August 21, 2026, with 35 shareholders present (5 promoters, 30 public). All 12 resolutions—including adoption of financials, reappointment of directors, appointment of auditors, increase in authorized share capital, change of company name, and various special resolutions—were passed unanimously with 100% votes in favour. Total votes polled were 796,353 out of 3,035,000 outstanding shares, representing a voter turnout of 26.24%.

• · Promoter group held 1,459,460 shares and voted 524,360 shares (35.93% of their holding).
• · Public non-institutional shareholders held 1,575,540 shares and voted 271,993 shares (17.26% of their holding).
• · No institutional shareholders (public or promoter) voted via e-voting or poll; only 244 votes were cast by public non-institutional shareholders via poll.
• · Resolutions included: increase in authorized share capital, change of company name, expansion of main object clause, approval for investments/loans/guarantees, creation of security/charges, and borrowing limits under Section 180(1)(c).
• · The promoter group was deemed interested only in Resolution 5 (increase in authorized share capital).

23-08-2026

Gland Pharma Limited has informed the stock exchanges of scheduled one-on-one meetings with Nomura on August 26, 2026, and with HDFC MF (arranged by Investec) on August 27, 2026. The meetings are part of routine investor engagement and do not contain any financial results or material business updates.

23-08-2026

Global Infratech & Finance Ltd has submitted its revised Annual Report for FY 2025-26 to BSE, noting no changes to the Balance Sheet or Profit & Loss figures, only to the numbering of Notes to Accounts. The company is seeking shareholder approval to raise up to ₹1.18958 Crore via a Qualified Institutional Placement (QIP) at the 31st Annual General Meeting scheduled for September 16, 2026. While the filing is a routine regulatory submission, the proposed QIP indicates a capital-raising initiative, though the amount is relatively small.

• · The Annual General Meeting will be held on September 16, 2026 at 12:15 PM via Video Conferencing.
• · Mr. V S Amarnath, appointed on January 21, 2026 up to January 20, 2029, is proposed for re-appointment as Director.
• · The QIP allotment must occur within 365 days from the date of the special resolution.
• · The QIP floor price will be determined per SEBI ICDR Regulations, with a permissible discount of up to 5%.
• · No single allottee can receive more than 50% of the QIP size, and allotted shares are locked in for one year.

23-08-2026

Donear Industries Limited has informed shareholders about tax deduction at source (TDS) on the recommended final dividend of ₹0.20 per equity share (face value ₹2) for FY 2025-26, subject to shareholder approval at the 40th AGM. The communication outlines TDS rates and documentation requirements for resident and non-resident shareholders, with a deadline of September 4, 2026, to submit forms to avoid higher deduction. This is a routine procedural update with no financial performance data or material business impact.

• · Dividend distribution tax has been abolished; dividend income is now taxable in shareholders' hands under the Income Tax Act, 1961 as amended by Finance Act, 2025.
• · Resident shareholders with total dividend exceeding ₹10,000 in FY 2026-27 are subject to 10% TDS if PAN is provided.
• · Non-resident shareholders (FIIs/FPIs) face 20% TDS (plus surcharge and cess) unless a lower tax treaty rate applies, requiring a valid Tax Residency Certificate and Form 41.
• · Shareholders must submit required documents via the dedicated link by September 4, 2026, 5:00 PM IST; late submissions will not be considered.
• · Failure to link PAN with Aadhaar will result in TDS at 20% under Section 397(2) of the Act.
• · SEBI mandates electronic payment of dividends to physical shareholders effective April 1, 2024, requiring PAN, nomination, bank details, and specimen signature.

23-08-2026

Nyssa Corporation Limited has called a Board Meeting on August 27, 2026, to consider and approve the sale of its stake in a proprietorship firm. The meeting is being convened under Regulation 29 of SEBI LODR Regulations, 2015. No financial details or prior-period comparisons are available in this filing.

• · The Board Meeting is scheduled for Thursday, August 27, 2026.
• · The agenda includes the sale of the company's stake in a proprietorship firm.
• · The filing is made under Regulation 29 of SEBI LODR Regulations, 2015.
• · The company's scrip code is 504378 on BSE.

23-08-2026

Dharan Infra-EPC Limited, currently under Corporate Insolvency Resolution Process (CIRP), disclosed that suspended directors, key managerial personnel (KMP), and the statutory auditor have failed to provide information and records sought by SEBI despite repeated summons and reminders. The company is under ongoing SEBI investigation, and the non-cooperation by these parties represents a serious compliance failure.

• · The company is under Corporate Insolvency Resolution Process (CIRP).
• · SEBI has issued repeated summons and reminders to the suspended directors, KMP, and statutory auditor.
• · The Interim Resolution Professional (IRP) is Palak Swapnil Desai (IBBI Reg. No: IBBI/IPA-001/IP-P-01517/2019-2020/12515).

23-08-2026

Gujarat Themis Biosyn Limited has informed the stock exchanges that shareholders approved an amendment to the Articles of Association (AOA) via a special resolution at an Extraordinary General Meeting (EGM) held on August 22, 2026. The amendment deletes a clause requiring a registered valuer's valuation report for share pricing in certain transactions, simplifying the language of Article 13(1)(c). This is a routine corporate governance update with no financial impact.

23-08-2026

Zydus Lifesciences Limited filed an investor presentation for a conference scheduled from August 24 to August 26, 2026. The presentation highlights the company's diversified business across India, US, and international markets, with a focus on innovation-led growth in formulations, consumer wellness, and MedTech. Key financial metrics include FY26 revenue of US$3.02 billion (₹2,71,484 Mn) and EBITDA of US$959 million (₹84,751 Mn), with a 15.5% revenue CAGR from FY22 to FY26. However, the 'Others' segment (API and Alliances) declined at a CAGR of -2.7% over the same period, and the Q1 FY27 EBITDA margin dropped to 24.1% from 31.2% in FY26, indicating a mixed near-term performance.

• · Zydus is #1 in Oncology in India (AWACS MAT June 2026) and #3 in the US generics market by prescriptions (IQVIA MAT June 2026).
• · The company has 7 brands among the top 300 brands of IPM.
• · Chronic therapy mix improved from 50.6% to 54.2% over 4 years (360 bps).
• · Zydus outperformed IPM in chronic therapies: 15.8% YoY growth vs 12% for IPM (MAT June 2026).
• · R&D spend in FY26 was US$257 million.
• · Market capitalization grew from ~US$4.7B in FY21 to US$11.7B as of August 21, 2026 (~2.5x).
• · ROCE improved by 730 bps from FY21 to current (21.6%).
• · The 'Others' segment (API and Alliances) declined at a CAGR of -2.7% from FY22 to FY26.
• · Q1 FY27 EBITDA margin was 24.1%, down from 31.2% in FY26; adjusted PAT margin was 11.9%, down from 20.1%.
• · Pipeline includes 210 products in the US, 33 505(b)(2) products, 13 biosimilars, and 12 vaccines under development.
• · Desidustat received marketing approval in China via partner.
• · Saroglitazar NDA filed for PBC in the US with priority review granted.
• · 16 biosimilars approved and 15 launched in India; marketing authorization in 19 emerging market countries.
• · 16 marketing authorizations across vaccine platforms; WHO PQ for Typhoid Conjugate and Rabies vaccine obtained.
• · MedTech focus areas: Orthopaedics, Cardiology, Nephrology; leveraging Amplitude Surgical platform for global expansion.

23-08-2026

Urban Company Limited disclosed a defamation and disparagement suit filed against Kent RO Systems Limited in the Delhi High Court on August 11, 2026, regarding false and misleading advertisements about Urban Company's NATIVE water purifiers. The court ordered Kent RO to pull down the offending advertisements within 15 days of August 12, 2026, and Kent RO agreed not to run similar disparaging ads. However, other legal matters between the two companies, including a patent infringement suit and a tortious interference suit, remain pending.

• · The suit was filed on August 11, 2026, and heard on August 12, 2026.
• · Kent RO's advertisements falsely claimed the 2-year filter life and service life feature of NATIVE purifiers is a 'marketing gimmick' and that using them is 'unsafe' and 'risky'.
• · Kent RO has 15 days from August 12, 2026, to pull down the offending advertisements.
• · The court order was published on August 22, 2026.
• · Other pending matters include a patent infringement suit by Kent RO (with a counterclaim by Urban Company) and a tortious interference suit by Urban Company.

23-08-2026

Eyantra Ventures Limited has informed BSE that a Board Meeting will be held on August 27, 2026 to consider and approve the consolidated unaudited financial results for the quarter ended June 30, 2026. The trading window will remain closed until August 29, 2026. This is a routine procedural disclosure with no financial figures or performance data.

• · Board meeting date: August 27, 2026
• · Trading window closure ends: August 29, 2026
• · Reference letter: EVL/BSE/2026-27/14 dated August 12, 2026

23-08-2026

IRB InvIT Fund has informed the exchanges that a board meeting of its Investment Manager, IRB Infrastructure Private Limited, is scheduled for August 26, 2026, to consider raising funds through issuance of units, non-convertible debentures, debt, or other permitted modes. The trading window for units of the Trust has been closed until further notice. No financial results or performance data are disclosed in this filing.

• · Board meeting date: August 26, 2026
• · Fund raising may include units, non-convertible debentures, debt, or other permitted modes under SEBI InvIT Regulations, 2014
• · Trading window is closed until further notice

23-08-2026

SBI Life Insurance Company Limited has informed the stock exchanges about a scheduled meeting with analysts/investors hosted by Morgan Stanley - India Financials Investor Group Trip in Mumbai on August 27, 2026. The company clarified that no unpublished price sensitive information will be shared during the meeting. This is a routine disclosure under Regulation 30 of SEBI LODR and does not contain any financial results or material business updates.

23-08-2026

Bondada Engineering Limited held its 14th Annual General Meeting (AGM) on August 21, 2026, via video conferencing. All eight resolutions proposed at the meeting were passed with overwhelming shareholder approval, with most resolutions receiving over 99.99% votes in favor. Notably, the resolution for approval of related party transactions saw 88.44% invalid votes (6,86,65,000 votes), but was still passed with the requisite majority. The AGM also approved a special resolution empowering the Board to borrow up to ₹10,000 Crore.

• · The AGM was held on August 21, 2026, at 3:00 PM IST and concluded at 3:53 PM IST.
• · Remote e-voting was open from August 18, 2026, 9:00 AM IST to August 20, 2026, 5:00 PM IST.
• · The cut-off date for eligibility to vote was August 14, 2026.
• · All resolutions were passed as Ordinary or Special Resolutions with the requisite majority.
• · The resolution for related party transactions had 6,86,65,000 invalid votes (88.44% of total votes), but was still passed.
• · The Board was empowered to borrow up to ₹10,000 Crore or aggregate of paid-up capital and free reserves, whichever is higher, under Section 180(1)(c).

23-08-2026

Siddheswari Garments Ltd. has informed the stock exchanges that a Board Meeting will be held on August 29, 2026, to adopt and approve the notice of the Annual General Meeting for FY 2025-2026. The filing is a routine corporate governance disclosure with no financial results or business updates.

• · Board Meeting scheduled for Saturday, August 29, 2026
• · Agenda includes adoption and approval of AGM notice for FY 2025-2026
• · No financial results, dividend, or other business items mentioned

23-08-2026

Gujarat Intrux Limited held a Board Meeting on August 23, 2026, approving the Directors' Report for FY2026, setting the 34th AGM for September 25, 2026 via virtual mode, and fixing the record date as September 18, 2026 for dividend and e-voting. The Board also approved a Power Purchase Agreement (PPA) with JP Power Solar Energy Private Limited for a 1120 KW solar power project, accepted the resignation of Company Secretary Sagar Rameshbhai Rajyaguru, and appointed Kishor Madhubhai Kikani as the new Company Secretary & Compliance Officer. No financial results or period-over-period comparisons were disclosed in this filing.

• · 34th Annual General Meeting scheduled for September 25, 2026 at 11:00 AM via video conferencing/OAVM.
• · Record date for dividend and e-voting fixed as September 18, 2026; Register of Members and Share Transfer Books closed from September 19 to September 25, 2026.
• · Mr. Kalpesh P. Rachchh appointed as scrutinizer for e-voting at the AGM.
• · Resignation of CS Sagar Rajyaguru effective August 23, 2026, to pursue career opportunities outside the company.
• · Appointment of Mr. Kishor Madhubhai Kikani (ACS 58545) as Company Secretary & Compliance Officer effective August 23, 2026; he has over 10 years of experience in corporate and secretarial laws.

23-08-2026

PAN HR Solution Ltd has submitted newspaper advertisements to BSE regarding its 11th Annual General Meeting scheduled for September 25, 2026, to be held via Video Conferencing/Other Audio-Visual Means. The advertisements were published in The Sunday Standard (English) and Dainik Savera Times (Hindi) on August 23, 2026, in compliance with Regulation 30 of SEBI LODR and MCA circulars. No financial figures or performance metrics were disclosed in this filing.

• · 11th Annual General Meeting scheduled for September 25, 2026
• · Meeting to be held through Video Conferencing (VC)/Other Audio-Visual Means (OAVM)
• · Advertisements published in The Sunday Standard (English) and Dainik Savera Times (Hindi) on August 23, 2026
• · Company formerly known as PAN HR Solution Private Limited

23-08-2026

Knowledge Marine & Engineering Works Limited has informed the stock exchanges that it will host an earnings call with analysts and investors on August 26, 2026, to discuss its operational and financial performance for the quarter ended June 30, 2026 (Q1 FY27). The company has stated that no price-sensitive information will be discussed during the call. No financial results or performance data are included in this filing.

• · The earnings call is scheduled for Wednesday, August 26, 2026, at 04:00 PM IST.
• · Dial-in numbers are provided for India, Hong Kong, Singapore, USA, and the UK.
• · Pre-registration is available to avoid wait time.

23-08-2026

Flex Foods Ltd. has informed the BSE that Mr. Arvind Mahajan has ceased to be an Independent Director effective from the close of business hours on August 23, 2026, upon completion of his 5-year term (August 24, 2021 – August 23, 2026). The change is due to term completion, not resignation or removal, and no replacement has been announced.

• · Mr. Arvind Mahajan's DIN is 02410540.
• · The company is BRC certified.
• · Corporate office: A-108, Sector-IV, Noida-201301; Registered office: Lal Tappar Industrial Area, Dehradun.

23-08-2026

Sayaji Hotels (Indore) Limited received an order from the District Excise Department, Indore, suspending its Hotel Bar (FL-3) Licence until the FSSAI suspension order is revoked or March 31, 2027, whichever is earlier. However, the Madhya Pradesh High Court has stayed the underlying FSSAI order dated August 21, 2026, and the company has informed the Excise Department of this stay. The exact financial impact is not yet ascertainable.

• · The Excise Department order was received on August 22, 2026.
• · The High Court stay on the FSSAI order was granted on August 22, 2026.
• · The company has apprised the Excise Department of the High Court's stay order.
• · The company states that any material impact or further development will be intimated to the stock exchange.

23-08-2026

Tirth Plastic Ltd has announced the outcome of its postal ballot and e-voting, which concluded on August 23, 2026. Shareholders approved the issuance of 45,00,000 fully convertible warrants on a preferential basis to non-promoter category at ₹30 per warrant, and the appointment of Ms. Nidhi Bharatbhai Gandhi as a Non-Executive Independent Director. The company will communicate the detailed voting results after receiving the scrutinizer's report.

• · Warrants are of ₹10 face value each, convertible into one equity share per warrant.
• · Issue price of ₹30 per warrant is based on a valuation report by a registered valuer.
• · Warrants are issued to persons belonging to the Non-Promoter Category.
• · Ms. Nidhi Bharatbhai Gandhi appointed as Non-Executive Independent Director.
• · Voting results will be communicated to the exchange after receipt of the scrutinizer's report and will be placed on the company's website.

23-08-2026

Gayatri Sugars Ltd. conducted a postal ballot through remote e-voting from July 21 to August 19, 2026, to seek shareholder approval for the appointment of Mrs. Sarita Danda (DIN: 11732470) as an Independent Director. The resolution passed overwhelmingly with 87.75% of valid votes in favour (3,102,374 votes from 126 members) and 12.25% against (379,924 votes from 9 members), with no invalid votes. The scrutinizer confirmed compliance with the Companies Act, 2013 and SEBI LODR Regulations.

• · The e-voting period ran from July 21, 2026 (9:00 AM IST) to August 19, 2026 (5:00 PM IST).
• · The cut-off date for determining eligible shareholders was July 10, 2026.
• · An advertisement regarding the postal ballot was published on July 21, 2026, as per Rule 22(3) of the Companies (Management and Administration) Rules, 2014.
• · Only remote e-voting was provided; no physical poll was conducted.
• · The scrutinizer's UDIN is A003785H001194326.

23-08-2026

Parmod Chand Joshi has resigned as Director of Shri Krishna Prasadam Ltd with immediate effect due to personal reasons. The resignation letter requests the company to file the necessary forms with the Registrar of Companies.

• · Resignation effective immediately as of the letter date (06/07/2026).
• · Director Parmod Chand Joshi's DIN is 08921222.
• · No reason beyond personal and unavoidable circumstances provided.

23-08-2026

GAIL (India) Limited has appointed Smt. Rupa Saikia as an Independent Director, effective from the date of the filing. The appointment was made in compliance with SEBI Listing Regulations and follows a prior intimation dated August 13, 2026. Smt. Saikia brings over 14 years of experience in education and human resource management, and she has no inter-se relationships with other directors.

• · Smt. Rupa Saikia holds DIN 11908368.
• · She is a Bachelor of Arts (B.A.) graduate.
• · She has served as Secretary in the Golaghat Zila Lekhika Samaroh, Assam.
• · She is not debarred from holding the office of Director by SEBI, Ministry of Corporate Affairs, or any statutory authority.
• · The appointment was intimated to both NSE (Scrip Code: GAIL-EQ) and BSE (Scrip Code: 532155).